266 related articles for article (PubMed ID: 10487477)
1. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection.
Inui K; Miyagawa H; Sashihara J; Miyoshi H; Tanaka-Taya K; Nishigaki T; Teraoka S; Mano T; Ono J; Okada S
Brain Dev; 1999 Sep; 21(6):416-9. PubMed ID: 10487477
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
4. Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies.
Manfredi R; Piergentili B; Marinacci G; Calza L
Int J STD AIDS; 2012 Mar; 23(3):e35-8. PubMed ID: 22581894
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for AIDS patients with progressive multifocal leukoencephalopathy.
Hernández B; Dronda F; Moreno S
Expert Opin Pharmacother; 2009 Feb; 10(3):403-16. PubMed ID: 19191678
[TBL] [Abstract][Full Text] [Related]
6. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
[TBL] [Abstract][Full Text] [Related]
7. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
Shah V; Toshniwal H; Shevkani M
J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
[TBL] [Abstract][Full Text] [Related]
8. [The inefficacy of zidovudine (AZT) in progressive multifocal leukoencephalopathy (PML) associated with the acquired immunodeficiency syndrome (AIDS)].
Garrote FJ; Molina JA; Lacambra C; Mollejo M; Madero S; del Ser T
Rev Clin Esp; 1990 Nov; 187(8):404-7. PubMed ID: 2091134
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy in an HIV patient receiving successful long-term HAART.
Mascarello M; Lanzafame M; Lattuada E; Concia E; Ferrari S
J Neurovirol; 2011 Apr; 17(2):196-9. PubMed ID: 21445699
[TBL] [Abstract][Full Text] [Related]
11. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.
Marzocchetti A; Cingolani A; Giambenedetto SD; Ammassari A; Giancola ML; Cauda R; Antinori A; Luca AD
J Neurovirol; 2005 Apr; 11(2):219-24. PubMed ID: 16036800
[TBL] [Abstract][Full Text] [Related]
12. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
[TBL] [Abstract][Full Text] [Related]
13. AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.
Roberts MT
CNS Drugs; 2005; 19(8):671-82. PubMed ID: 16097849
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy--as a presenting manifestation of AIDS.
Raina S; Kaushal SS; Gupta D; Himral P; Sawal N; Sood V; Goyal A
J Assoc Physicians India; 2007 Nov; 55():797-801. PubMed ID: 18290557
[TBL] [Abstract][Full Text] [Related]
15. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
[TBL] [Abstract][Full Text] [Related]
16. Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction.
Monno L; Di Stefano M; Zimatore GB; Andreula CF; Appice A; Perulli LM; Fiore JR; Pastore G; Angarano G
AIDS; 1998 Apr; 12(6):581-90. PubMed ID: 9583597
[TBL] [Abstract][Full Text] [Related]
17. Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?
Di Giambenedetto S; Vago G; Pompucci A; Scoppettuolo G; Cingolani A; Marzocchetti A; Tumbarello M; Cauda R; De Luca A
Neurology; 2004 Dec; 63(12):2452-3. PubMed ID: 15623736
[No Abstract] [Full Text] [Related]
18. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
[TBL] [Abstract][Full Text] [Related]
19. AIDS presenting as progressive multifocal leukoencephalopathy with clinical response to zidovudine.
Singer EJ; Stoner GL; Singer P; Tomiyasu U; Licht E; Fahy-Chandon B; Tourtellotte WW
Acta Neurol Scand; 1994 Dec; 90(6):443-7. PubMed ID: 7892765
[TBL] [Abstract][Full Text] [Related]
20. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
